In vivo, hypoxia is known to damage the blood-brain barrier (BBB) leading to the development of vasogenic brain edema. Primary cultures of porcine brain derived microvascular endothelial cells were used as an in vitro BBB model to evaluate the mechanisms by which hypoxia regulates paracellular permeability. Paracellular passage across endothelial cell monolayers is regulated by specialized intercellular structures like the tight junctions (TJ). Zonula occludens-1 (ZO-1), a protein of the TJ, lines the cytoplasmic face of intact TJ. The continuity of the ZO-1 expression was disrupted during 24 h of hypoxia which correlated with a decrease of the protein level to 32 ؎ 8% and with a twofold increase in the phosphorylation of ZO-1 in comparison to values determined at the start of the experiment. The localization and expression level of ZO-1 were maintained during hypoxia in the presence of a polyclonal antibody to vascular endothelial growth factor (VEGF) demonstrating that hypoxia-induced changes of the ZO-1 expression are mediated by VEGF. The effect of hypoxia on the ZO-1 distribution probably is not tissue-or cell-specific because similar changes of ZO-1 distribution were observed when the rat brain endothelial cell line RBE4 or the murine epithelial cell line CSG was used. Furthermore, ZO-1 changes correlated with small changes in actin distribution. These results suggest that hypoxia increases the paracellular flux across the cell monolayer via the release of VEGF, which in turn leads to the dislocalization, decreased expression, and enhanced phosphorylation of ZO-1.
INTRODUCTION
Tissues of the central nervous system like the brain depend on an intact blood-brain barrier (BBB), which exists at the level of the endothelial cells (Brightman and Reese, 1969) . This barrier regulates and limits the amount of trans-and paracellular flux (Abbott and Revest, 1991) and thus contributes to the maintenance of a specific neural tissue environment. The barrier properties of the BBB result from the absense of fenestrations, the low number of pinocytotic vesicles, and the presence of tight intercellular junctions between the endothelial cells (Crone and Olesen, 1982) . Tight junctions (TJ) contain at least seven proteins including the transmembrane proteins occludin and claudins and cytoplasmic proteins like zonula occludens-1, -2, and -3 (ZO-1, -2, or -3), cingulin, the 7H6 antigen, and symplekin (reviewed in Anderson and Van Itallie, 1995; Kim, 1995; Balda and Matter, 1998; Mitic and Anderson, 1998; Yap et al., 1998) . Of these, ZO-1, a 220-kDa phosphoprotein located on the cytoplasmic face of the plasma membrane, has been the best characterized (Stevenson et al., 1986) . ZO-1 belongs to a family of multidomain proteins known as the membrane-associated guanylate kinase homologs (MAGUKs) . It has been demonstrated to interact with the transmembrane protein occludin, ZO-2 and F-actin, although the nature and functional significance of these interactions are poorly understood (Fanning et al., 1998) . The functional importance of ZO-1 protein has been suggested by results such as its increased expression in parallel with electrical resistance values and its upregulation by astrocyte-conditioned medium in cultured endothelial cells (Krause et al., 1991; Gardner, 1995) . Therefore, ZO-1 protein levels respond to physiological influences and participate in the regulation of paracellular permeability through TJ.
It is well known that many pathological conditions lead to an opening of the BBB through transcellular or paracellular pathways (Abbott and Revest, 1991) . Pathological conditions like local ischemia or brain tumors, associated with disruption of the BBB, lead to the development of vasogenic brain edema (Baethmann, 1978) . A likely candidate for the development of ischemia-induced vasogenic brain edema is vascular endothelial growth factor (VEGF), also known as vascular permeability factor. VEGF stimulates endothelial cell growth and migration in vitro (Ferrara and Henzel, 1989; Senger et al., 1996) and angiogenesis in vivo (Connolly et al., 1989; Leung et al., 1989) and increases vascular permeability (Senger et al., 1986; Yeo et al., 1991; Dvorak et al., 1995; Roberts and Palade, 1995; Wu et al., 1996) . VEGF-induced endothelial hyperpermeability is caused by a direct action on endothelial cells (Hippenstiel et al., 1998) and is suggested to mediate enhanced transcytosis and gap formation between endothelial cells (Collins et al., 1993; Criscuolo, 1993) and to induce fenestrations in nonfenestrated endothelium Palade, 1995, 1997) . Recently, we demonstrated that hypoxia-induced permeability in vitro is mediated by the VEGF/VEGF receptor system in an autocrine manner which is essentially dependent on reducing conditions stabilizing the second messenger NO as the mediator of changes in barrier function of brain derived microvascular endothelial cells (BMEC) (Fischer et al., 1998) .
These studies were performed to gain insight in the role of ZO-1 under conditions associated with increased permeability. We examined whether hypoxia induced an increase in paracellular permeability by changing the distribution or expression level of ZO-1. Furthermore, the role of VEGF in hypoxia-induced changes of ZO-1 expression was investigated.
MATERIALS AND METHODS

Cell Culture
Capillary endothelial cells were isolated from porcine brains as described previously (Mischek et al., 1989) . The gray matter was digested with dispase II (0.8 mg/100 ml) for 3 h at 37°. Capillaries were isolated after centrifugation with 15% dextran. The pellet was resuspended in Medium M199 and treated with collagenase/dispase (1 mg/ml) for 5 h at 37°. Endothelial cells were obtained after Percoll gradient centrifugation. Cells were seeded on Biocoat petri dishes (Becton-Dickinson, Heidelberg, Germany) or on rat tail collagen I (Becton-Dickinson) coated polycarbonate transwell inserts with a pore size of 0.4 m and a diameter of 12 mm (Millipore, Eschborn, Germany) and incubated at 37°in a 5% CO 2 -humidified incubator. The cells were grown in M199 medium supplemented with 20% [v/v] fetal calf serum (FCS), 200 units/ml penicillin, 200 units/ml streptomycin, and 2.5 g/ml amphotericin B. All ingredients were purchased from Life Technologies (Eggenstein, Germany). After 7 days, the primary cultures formed confluent monolayers. Cells were characterized by analyzing endothelial marker enzymes like alkaline phosphatase and ␥-glutamyltransferase activity using assay kits from Sigma (Munich, Germany). Furthermore, the uptake of acetylated low-density lipoprotein (Dil-Ac-LDL) (Paesel & Lorei, Frankfurt, Germany) (Voyta et al., 1984) and the expression of glucose transporter I were used as markers for cerebral endothelial cells. Pericytes and astrocytes were characterized by immunofluorescence staining with anti ␣-smooth muscle actin (Sigma) and anti glial fibrillary acidic protein (Boehringer, Mannheim, Ger-many) antibodies. Cultures used for our experiments contained fewer than 5% pericytes. Cells of astroglial origin could only be detected in some cultures but their content was always less than 1%. The endothelial cell line RBE4 from rat brain and murine submandibular gland carcinoma cells, named CSG, was cultured as described (Durieu-Traumannm et al., 1991; Bamforth et al., 1999) .
In Vitro Hypoxia Model
To induce hypoxia, confluent monolayers of BMEC, RBE4, or CSG were washed once with phosphatebuffered saline, pH 7.4 (PBS), M199 medium without FCS in the absence or presence of added compounds and culture plates were placed into special chambers equipped with a thermostat housing which allows incubation of the chambers at 37°. Chambers were incubated at 37°under either normoxic or hypoxic conditions (2% oxygen) by gassing the special chamber with a gas mixture consisting of 95% air and 5% CO 2 or 93% N 2 , 2% O 2 , and 5% CO 2 . For control, the concentration of oxygen in the culture incubation medium after different time periods of hypoxia was determined using a digital O 2 -meter (Schott Geräte GmbH, Germany). The respiratory activity of cells did not change the oxygen content in the culture medium significantly. The pH of the medium was unchanged during up to 24 h of hypoxia. For control, cultures were incubated under normoxic conditions for the same length of time.
Immunocytochemistry
BMEC, RBE4, or CSG were grown either on normal Biocoat petri dishes or on plastic slides. For staining, monolayers were washed twice with PBS, fixed in 1% paraformaldehyde at 4°for 15 min, washed with PBS, permeabilized with 0.05% Triton for 10 min, and washed again five times with PBS. Samples were blocked with 10% normal goat serum (Sigma) for 30 min at room temperature, followed either by 1 h of incubation with rabbit-polyclonal anti-ZO-1 (1:1000, Dianova, Hamburg, Germany) or with tetramethylrhodamine-5(-6) isothiocyanate phalloidin (1 g/ml; Sigma). After being washed with PBS, nuclei of cells treated with phalloidin were stained with 4,6-diamidino-2-phenylindole for 1 min. The samples were viewed with a fluorescent photomicroscope (Leica, Bensheim, Germany). Cells treated with the antibody to ZO-1 were incubated for 1 h at room temperature with goat anti-rabbit-Cy3 (1:400, Dianova) followed by washing, staining of nuclei, and microscopy as described for phalloidin-treated cells.
For the quantification of F-actin, confluent monolayers of BMEC were washed, fixed, and incubated for 1 h at room temperature with phalloidin as described for immunocytochemistry. After the cells were washed with PBS, bound phalloidin was extracted using methanol. The concentration of phalloidin was determined by measurements of the fluorescence ( exc ϭ 542 nm; em ϭ 563 nm).
Immunoprecipitation and Western Blotting
Cells grown on normal petri dishes were washed with PBS and lysed with a minimal volume of ice-cold lysis buffer (1% Triton X-100, 0.4% SDS, 1 mM EDTA, 10 mM tris(hydroxymethyl)aminomethane-HCl (pH 7.4) with a protease inhibitor mix containing 1 g/ml leupeptin, chymostatin, pepstatin, 1 mM benzamidine, and 5 mM 4-(2-aminoethyl)-benzenesulfonyl fluoride. The lysates were rocked at 4°for 1 h, and cytoskeletal elements and DNA were pelleted at 14,000 revolutions/min (rpm/min) for 5 min. A total of 100 g of the supernatant was precleared with uncoupled protein A Sepharose for 1 h at 4°followed by immunoprecipitation with anti-ZO-1 antibody. Samples of 50 g protein were subjected to SDSpolyacrylamide gel electrophoresis as described by Laemmli and Favre (Laemmli, 1970) , followed by Western blotting. To ensure that equal amounts of proteins were loaded on the gel and transferred to the filter membrane, the membrane was stained with Ponceau solution (25% Ponceau, 40% methanol, 1.5% acetic acid). After restaining, the nitrocellulose filter was blocked with 5% (w/v) bovine serum albumin in PBS buffer (10 mM sodium phosphate, pH 7.4, 150 mM NaCl, 0.1% Tween 20) and incubated with a rabbitpolyclonal anti-ZO-1 antibody (1:1000, Dianova) or with a mouse anti-phosphotyrosine antibody (1:1000, Sigma) followed by HRP-conjugated goat anti-rabbit or goat anti-mouse (1:4000). Detection was performed using the ECL chemiluminescent kit from Amersham (Amersham, Buchler, Germany).
Statistical Analysis
Results were expressed as the means Ϯ SEM. Unpaired Students t test or analysis of variance and subsequent multiple comparisons using Dunn's method was used for statistical analysis. Results were considered statistically different at P Ͻ 0.05.
RESULTS
Effect of Hypoxia on the Distribution and Expression of ZO-1
In confluent cultures of BMEC, ZO-1 staining has a very discrete and continuous junctional location.
Twenty-four hours of hypoxia changed the continuous staining of ZO-1 in confluent cultures to a diffuse and discontinuous localization of ZO-1 at regions of cell-cell contact as already shown (Fischer et al., 2000) .
To quantify ZO-1 expression during hypoxia, ZO-1 expression in BMEC after different hypoxic periods was examined by immunoblotting. Whole cell lysates were prepared and equal amounts of total protein were resolved by one-dimensional gel electrophoresis. Immunoblotting was performed using the polyclonal anti-ZO-1 antibody. Quantification of the ZO-1 expression by densitometry showed that hypoxia decreased the ZO-1 level in a time-dependent manner. After 24 h of hypoxia, the protein level decreased to 32 Ϯ 8% (Fig. 1) . During 24 h of normoxia, ZO-1 expression is not changed.
During the same time the phosphorylation of the ZO-1 protein increased twofold. The maximal rate of phosphorylation was found after 3 h of hypoxia (Fig.  2) , whereas during normoxia, the amount of phosphorylated ZO-1 is not changed.
Involvement of VEGF in Hypoxia-Induced Changes of ZO-1 Dislocalization and Expression
To determine whether VEGF is involved in hypoxiainduced changes of the ZO-1 distribution, BMEC were cultured in the presence of a neutralizing antibody to VEGF under hypoxic conditions followed by immunohistochemistry. The presence of the VEGF antibody prevented hypoxia-induced redistribution of ZO-1 (Fig. 3) .
Further experiments were performed to evaluate whether VEGF can induce changes similar to those of hypoxia in the ZO-1 distribution. Earlier experiments demonstrated that VEGF only increased the permeability in the presence of antioxidants (Fischer et al., 1999) . Therefore, VEGF at the concentration of 5 ng/ml in the presence of ␣-lipoic acid (LA) was added to BMEC cultures and incubated under normoxic conditions for 24 h. Indeed, under these conditions, the cellular distribution of ZO-1 was disturbed in the same manner as during 24 h of hypoxia. For control, it was shown that LA as well as VEGF alone did not change the ZO-1 localization (data not shown).
The involvement of VEGF in hypoxia-induced ZO-1 expression and phosphorylation was further investigated by Western blot analysis (Fig. 4) . For these studies incubation times of 3 h were used, because 3 h of hypoxia decreased the ZO-1 protein level significantly and increased the phosphorylation of ZO-1 the most. The decrease of the ZO-1 protein expression after 3 h of hypoxia was prevented in the presence of a polyclonal antibody to VEGF. Additionally, VEGF in combination with LA decreased the ZO-1 expression to nearly the same extent as 3 h of hypoxia.
Furthermore, phosphorylation of ZO-1, induced by 3 h of hypoxia, was prevented in the presence of the VEGF antibody. VEGF in combination with LA increased phosphorylation to the same extent as hypoxia (Fig. 5) .
Effect of Hypoxia on ZO-1 Distribution in RBE4 and CSG
To investigate whether the effect of hypoxia on endothelial cells is tissue-and cell-specific, the effect of BMEC were cultured to confluency on rat tail collagen I coated coverslips. Subsequently, cells were incubated for 24 h under normoxic (A) or hypoxic conditions in the absence (B) and presence of a polyclonal antibody to VEGF (10 g/ml) (C) and after treatment with VEGF (5 ng/ml) and LA (2 M) (D). Cells were then fixed and stained with anti-ZO-1 antibody. Bar ϭ 13.4 m.
hypoxia on the ZO-1 distribution in rat brain endothelial cells and murine submandibular gland carcinoma cells was examined. Also in RBE4 and CSG cells, ZO-1 is localized at the cell membrane. In RBE4 cells the staining of ZO-1 shows a more discontinuous localization around the membrane compared to BMEC and CSG cells. This is in accordance to the low resistance values, which were determined after culturing RBE4 cells on filter membranes (20 -30 ⍀cm 2 ). Hypoxia disrupted the ZO-1 expression around the membrane and induced the formation of gap junctions in RBE4 cells. In CSG cells, hypoxia led to a more ruffled staining of ZO-1 along the cell membrane. Hypoxiainduced changes in RBE4 and CSG cells were reversed in the presence of the neutralizing VEGF antibody (Fig. 6) .
Effect of Hypoxia on the Localization of F-Actin
Because the ZO-1 protein is linked to the cytoskeletal protein F-actin, in addition the effect of hypoxia on the distribution of F-actin was examined. After 24 h of normoxia in BMEC, RBE4, and CSG cells F-actin is located around the cell membrane. Some expression was also found in the cytoplasma. After 24 h of hypoxia, the F-actin distribution slightly changed and showed more stress fiber patterns. The amount of BMEC were cultured for 3 h under normoxic conditions in the presence of VEGF (5 ng/ml) (N ϩ VEGF), LA (2 M; N ϩ LA), or both (VEGF ϩ LA) and under hypoxic conditions in the absence (H) and presence of a polyclonal antibody to VEGF (10 g/ml) (HϩVEGF-Ab), extracted, immunoprecipitated with anti ZO-1 antibody, and processed for immunoblotting using a monoclonal antibody to phosphotyrosine. (B) Quantification of the ZO-1 phosphorylation. The value determined after 3 h of normoxia was set to 100%. The values represent the means Ϯ SEM from four different experiments (*P Ͻ 0.05 different from the corresponding value determined after 3 h of normoxia).
FIG. 4. (A) Effect of VEGF on the expression of ZO-1 protein.
BMEC were cultured for 3 h under normoxic conditions in the presence of VEGF (5 ng/ml) (NϩVEGF), LA (2 M; N ϩ LA), or both (VEGF ϩ LA) and under hypoxic conditions in the absence (H) and presence of a polyclonal antibody to VEGF (10 g/ml) (H ϩ VEGF-Ab), lysed, electrophoresed, and processed for immunoblotting with the antibody to ZO-1. (B) Quantification of the ZO-1 expression. The value determined after 3 h of normoxia was set to 100%. The values represent the means Ϯ SEM from four different experiments (*P Ͻ 0.05 different from the corresponding value determined after 3 h of normoxia).
F-actin, however, did not change significantly during 24 h of hypoxia as determined in BMECs (Fig. 7) .
DISCUSSION
In previous studies we showed that hypoxia increased the permeability to [ 3 H] inulin in an in vitro model of the blood-brain barrier consisting of brain derived microvascular endothelial cells. As inulin is a marker which crosses the BBB via the paracellular pathway, it is suggested that hypoxia may alter tight junction assembly. This study shows that hypoxia disrupted the continuous pericellular distribution of the tight junction protein ZO-1. Associated with these changes was a significant loss of ZO-1 protein expression in a time-dependent manner. This is in accordance with other studies describing that the ZO-1 protein content corresponds inversely with the permeability of a cell monolayer consisting of brain capillary endothelial cells (Krause et al., 1991) . Furthermore, the vasoactive agent histamine has been shown to reduce ZO-1 protein expression within the time associated with increased paracellular permeability (Gardner et al., 1996) . Therefore, it is suggested that tight junction protein alterations may be a mechanism by which microvascular permeability is increased. Further stud- ies are in progress to evaluate whether hypoxia either down regulates ZO-1 synthesis or increases its degradation. The decrease of the ZO-1 level after treating cells with interferon ␥, for example, is mediated by an increase in protein turnover, decreased protein synthesis, and a reduction in mRNA level (Youakim and Ahdieh, 1999) . The analysis of ZO-1 mRNA levels will help to clarify the mechanism by which hypoxia decreases ZO-1 levels in our system.
We have shown that VEGF, released during hypoxia by BMEC (Fischer et al., 1998 (Fischer et al., , 2000 , is the mediator of hypoxia-induced permeability changes by inducing the release of NO (Fischer et al., 1999) . NO itself only increased the permeability in the presence of antioxidants to prevent rapid autoxidation reactions of NO. Our results demonstrate that hypoxia-induced changes of the localization and protein expression of ZO-1 were prevented in the presence of a neutralizing, polyclonal antibody to VEGF. Accordingly, VEGF added to BMEC cultures in the presence of antioxidants changed the ZO-1 distribution in the same manner as hypoxia. These results suggest that hypoxiainduced hyperpermeability, mediated by VEGF, involves changes of the ZO-1 distribution and expression. Also, other studies demonstrate that VEGF induces rearrangement and changed expression of endothelial junctional proteins (Kevil et al., 1998; Wang et al., 2001) . In contrast to our results, Kevil et al. (Kevil et al., 1998) demonstrated that VEGF added to bovine brain microvascular endothelial cells rearranged the localization of ZO-1, whereas the protein expression remained unchanged. They further demonstrate that VEGF-induced permeability changes involve the mitogen-activated protein (MAP) kinase signal transduction pathway, because permeability changes were blocked after adding PD98059, a specific inhibitor of MAP kinases. We propose that in our system VEGF released during hypoxia induces hyperpermeability and changes of the ZO-1 expression by another mechanism, because hypoxia-induced permeability changes were not inhibited by PD98059 (data not shown). Further studies are necessary to clarify the mechanism by which hypoxia changes permeability and ZO-1 expression.
The cDNA sequence of ZO-1 demonstrates that this protein belongs to a family of proteins of putative signaling proteins called MAGUKs (Anderson and Van Itallie, 1995) . All members of this family have an SH3 domain, one region of homology to guanylate kinase (Willott et al., 1993) , and three PDZ domains, consisting of approximately 90-amino-acid domains, which seem to bind to neighboring proteins (Cho et al., 1992) . In addition, they all share a conserved tyrosine residue. Accordingly, ZO-1 is known as a target for tyrosine kinases in epithelium (Kurihara et al., 1995) and also in umbilical endothelial cells. Thus, it is suggested that phosphorylation of tight junction proteins likely contributes to regulated endothelial paracellular permeability (Antonetti et al., 1999) . In our system, consisting of BMEC, hypoxia as well as the treatment with VEGF and antioxidant induced the tyrosine phosphorylation of ZO-1 twofold. Neutralizing VEGF antibody prevented hypoxia-induced phosphorylation. These results suggest that the protein phosphorylation of ZO-1 probably is involved in the regulation of endothelial barrier permeability of BMEC caused by hypoxia and VEGF in the presence of antioxidants.
The effect of hypoxia on the ZO-1 distribution also was observed when the rat brain endothelial cell line RBE4 or the murine epithelial cell line CSG was used. CSG cells displayed a slightly different pattern of changes in ZO-1 than BMEC and RBE4. CSG are known to form tighter junctions than brain endothelial cells in culture and show a more continuous staining of ZO-1 along the cell membrane. Accordingly, CSG monolayers develop much higher resistance values (about 2000 ⍀cm 2 ) (Bamforth et al., 1999) . After 24 h of hypoxia, ZO-1 staining of CSG nearly looks like that of BMEC after 24 h of normoxia. After that time the hypoxia resistance values of CSG are still higher than those determined for BMEC after 24 h of normoxia (data not shown). Accordingly, changes in ZO-1 distribution probably are not so obvious as those observed after the same amount of hypoxia in BMEC. The antibody to VEGF abolished the effect of hypoxia on ZO-1 distribution, suggesting that VEGF also may function as mediator of these changes in RBE4 and CSG cells and that the effect is not tissue-or cellspecific. Nevertheless, further studies are necessary to clarify whether the mechanism of hypoxia-induced permeability changes in RBE4 and CSG is similar to that elucidated so far in BMEC.
The association of ZO-1 with tight junctions is mediated by two separate domains within the NH 2 -terminal half of ZO-1 (Fanning et al., 1998) . ZO-1 also interacts with the cytoskeleton either by binding to spectrin (Itoh et al., 1991) or by binding directly to actin (Itoh et al., 1997) . The actin binding activity of ZO-1 has been mapped to the COOH-terminal half of the molecule (Fanning et al., 1998) . Thus, ZO-1 may act as a direct or indirect link among the transmembrane component of the tight junction, occludin, and the cytoskeleton.
Therefore, changes in actin distribution would be expected. The distribution of actin filaments in untreated cells is located at the cell membrane. During hypoxia they assemble in a less-organized pattern of cytoplasmic filaments. Accordingly, it was shown that increased junction permeability corresponds to stress fiber formation (Schulze et al., 1997) . Nevertheless, the amount of actin was not changed. On the basis of our experiments it is not possible to distinguish whether loss of ZO-1 protein is responsible for the small changes in actin distribution or whether changes in actin distribution decrease ZO-1 protein. Further experiments are in progress to evaluate this point more exactly.
Conclusively, our data demonstrate that hypoxia increases the paracellular flux across the cell monolayer via the release of VEGF as shown before (Fischer et al., 1998 (Fischer et al., , 2000 , which in turn leads to the dislocalization, decreased expression, and enhanced phosphorylation of ZO-1. Nevertheless, other tight junction components might also be altered. Therefore, further studies are necessary to investigate the effects of hypoxia on the expression of other tight junction proteins in our system. The mechanism for inducing hypoxiainduced permeability changes in BMEC seems to be a general one because hypoxia-induced changes in the ZO-1 and actin distribution in the rat endothelial cell line RBE4 and also in the murine epithelial cell line CSG were prevented in the presence of a neutralizing antibody to VEGF.
